Weirich J, Antoni H
Physiologisches Institut, Universität Freiburg i. Br, Germany.
Basic Res Cardiol. 1998;93 Suppl 1:125-32. doi: 10.1007/s003950050236.
Rate or frequency-dependence is a characteristic property of antiarrhythmic drugs belonging to the Vaughan William classes I and III. The rate-dependence of class I drugs (i.e., increasing blockade of fast Na(+)-channels with faster rates) results from periodical drug binding to Na(+)-channel sites which are preferably available in the activated and/or inactivated channel states (use-dependence). With respect to their binding and unbinding kinetics, class I drugs can be subdivided into three groups (group 1-group 3) which differ in their block-frequency relations as well as in their onset kinetics of channel blockade. These properties can serve as predictors of the anti- and proarrhythmic potential of class I drugs. Class III drugs (blockers of potassium channels) are mostly characterized by reverse rate-dependence (loss of class III action at faster rates). However, this property cannot be attributed to reverse use-dependence, i.e., binding to channels in the rested state. It is more likely due to different rate-dependent contributions of the two components of the delayed rectifier potassium current to repolarization, when the rapidly activating, the rectifying component IKr is specifically blocked by class III drugs, while the slowly activating component IKs remains unchanged. In spite of their reverse rate-dependence, class III drugs exert an antifibrillatory effect when fibrillation is induced by frequent stimulation. This can be attributed to the slow time course of the decline (offset kinetics) of the class III effect accompanying a sudden increase in frequency. Proarrhythmic effects of class III drugs result from the delay in repolarization that may favor the development of early afterdepolarizations. The proarrhythmic potential of class III drugs is species dependent and is favored if the contribution of IKr to the repolarization phase of the action potential is comparatively large.
速率或频率依赖性是属于 Vaughan Williams 分类 I 类和 III 类抗心律失常药物的一个特征性属性。I 类药物的速率依赖性(即随着速率加快,对快速钠通道的阻滞增加)源于药物与钠通道位点的周期性结合,这些位点在通道的激活和/或失活状态下更容易出现(使用依赖性)。就其结合和解离动力学而言,I 类药物可分为三组(1 组至 3 组),它们在阻滞频率关系以及通道阻滞的起效动力学方面存在差异。这些特性可作为 I 类药物抗心律失常和促心律失常潜力的预测指标。III 类药物(钾通道阻滞剂)大多具有反向速率依赖性(在较快速率下失去 III 类作用)。然而,这种特性不能归因于反向使用依赖性,即与静息状态下的通道结合。更可能是由于延迟整流钾电流的两个成分对复极化的不同速率依赖性贡献,当快速激活的整流成分 IKr 被 III 类药物特异性阻滞,而缓慢激活成分 IKs 保持不变时。尽管具有反向速率依赖性,但当通过频繁刺激诱发纤颤时,III 类药物仍发挥抗纤颤作用。这可归因于频率突然增加时 III 类效应下降的缓慢时间进程(抵消动力学)。III 类药物的促心律失常效应源于复极化延迟,这可能有利于早期后除极的发生。III 类药物的促心律失常潜力因物种而异,如果 IKr 对动作电位复极化阶段的贡献相对较大,则更易出现促心律失常作用。